Latest Articles
‘No surgery, no chemo’: new cancer trial shows 100% remission with immunotherapy - Mathrubhumi English
‘No surgery, no chemo’: new cancer trial shows 100% remission with immunotherapy Mathrubhumi English
Published: May 6, 2025, 10:03 a.m.
Second Immunotherapy Exposure: Understanding Efficacy and Safety in Endometrial and Cervical Carcinoma - OncLive
Second Immunotherapy Exposure: Understanding Efficacy and Safety in Endometrial and Cervical Carcinoma OncLive
Published: April 28, 2025, 1:18 p.m.
Rethinking Immunotherapy: A Case for Personalization in Advanced Endometrial Cancer - HMP Global Learning Network
Rethinking Immunotherapy: A Case for Personalization in Advanced Endometrial Cancer HMP Global Learning Network
Published: April 11, 2025, 2:54 p.m.
S2 Episode 4: Immunotherapy Insights and Research in Endometrial Cancer - Medscape
S2 Episode 4: Immunotherapy Insights and Research in Endometrial Cancer Medscape
Published: April 10, 2025, 2:07 p.m.
Adoptive transfer of regulatory T cells inhibits the progression of endometriosis-like lesions in regulatory T-cell-depleted mice.
Does the restoration of regulatory T cells (Tregs) suppress the progression of endometriosis?
Published: April 3, 2025, midnight
Endometrial cancer patients to receive funded immunotherapy - Hong Kong Standard
Endometrial cancer patients to receive funded immunotherapy Hong Kong Standard
Published: March 27, 2025, 9:09 a.m.
Immunopathology of Endometriosis, Molecular Approaches.
Endometriosis (EMS) is a common chronic gynecological disorder affecting 5%-10% of reproductive-age women, often causing infertility, dyspareunia, pain, and limitations in physical and sexual activities. This condition is defined by …
Published: March 26, 2025, midnight
Immunotherapy Continues to Redefine Treamtent Considerations in Advanced/Recurrent Endometrial Cancer - OncLive
Immunotherapy Continues to Redefine Treamtent Considerations in Advanced/Recurrent Endometrial Cancer OncLive
Published: March 6, 2025, 2:32 p.m.
Single-cell sequencing reveals the role of aggrephagy-related patterns in tumor microenvironment, prognosis and immunotherapy in endometrial cancer - Frontiers
Single-cell sequencing reveals the role of aggrephagy-related patterns in tumor microenvironment, prognosis and immunotherapy in endometrial cancer Frontiers
Published: March 4, 2025, 1:24 p.m.
Dr Hinchcliff on the Benefits of Chemoimmunotherapy in Endometrial Cancer - OncLive
Dr Hinchcliff on the Benefits of Chemoimmunotherapy in Endometrial Cancer OncLive
Published: Feb. 21, 2025, 9:57 p.m.
Link copied to clipboard!